Welcome, Paramount. Thank you for taking the time to consider Express Scripts. Our team valued having you as a client and would love to have you back, to take on your toughest health care challenges, and push the limits of what we can accomplish – together. From where you sit in the organization, you probably realize health care is more complicated than it needs to be. What if you could be part of the solution to transform health care as we know it – to make it more affordable, predictable and simple?
The future of health care starts here: Welcome, Paramount

Nice to e-meet you
Learn about the leadership and finalist teams for Paramount.

Transforming care ... together
Hear from Tim Wentworth, President of Health Services, about how we focus on your growth priorities.
See how we helped a client grow their Medicare business
We offer the guidance and support necessary to help our clients improve in quality outcomes and Star ratings.
Implementation and innovation success story
Hear about a real clients' experience implementing their plan and their clients with Express Scripts.
Your trusted partner in regulated markets
We're squarely focused on the quality metrics that are important to you and know that our support will help you move the needle on becoming market-leading – today and in the future. Through our clinical programs, network strategy, formulary management and levers designed specifically for regulated markets, we want to be Paramount's partner of choice.

When you win, we all win
With our partnership, our health plan clients are investing in their sales teams to expand their pharmacy knowledge, modernize their offerings and employ proven strategies and tactics to help them compete more effectively than ever before. Hear from a current client about what they value about our partnership and commitment with grow and win together.
Fragmented drug management strategies may be costing you
Medical drug spending is expected to increase by 33% by 2023. With specialty costs rising rapidly, you may be seeking new ways to manage spend and optimize administrative efficiencies. See how our approach to integrating medical drug management optimizes drug savings across pharmacy and medical benefits, enabling better efficiency, greater savings and improved safety.
of claims in the highest specialty spend categories are duplicating work within plans.
higher specialty drug approvals vs. traditional approvals within the last 4 years.1
projected medical spend in 2023 – a 33% increase from $96B in 2018.2
Innovating for the future of health care
If you haven't seen us lately, you haven't seen us. As quickly as the health care landscape evolves, we're constantly innovating in turn, to help our clients stay ahead and achieve better clinical and financial outcomes. We're committed to unlocking new value and taking on your toughest challenges through innovation that benefits you, your members and health care as a whole.

Experience The Lab
See where innovation comes to life at The Lab in Saint Louis, Missouri. Engage with our innovative teams who are changing health care from the inside out, and come face-to-face with what's possible.



Aligned with Paramount, we'll deliver world-class health services with a singular focus: to make health care more affordable, predictable and simple.
AFFORDABLE
We build on our leading, differentiated position to lower the total cost of care
PREDICTABLE
We take surprise out of the system and help people make informed health care choices
SIMPLE
We make it easier for the people we serve to get the care they need
Learn more
We're committed to helping health plans grow. I look forward to continuing the conversation about how we can help Paramount.
Do you have any questions? I'm here to help.
References:
1. FDA traditional and specialty approvals for 2016 – projected 2019 – does not include vaccines and diagnostic tests, as of September 2019
2. Evaluation using data from 2018 Altarum institute projection of non-retail drug expenditure for Medical Benefit Growth Rate; CMS, IQVIA and the 2019 Economic Report on US Pharmacies and PBMs, Drug Channels. Analysis assumes most medical drug spend is specialty.
3. Deloitte 2018 Study: The Convergence of Health Care Trends
1. FDA traditional and specialty approvals for 2016 – projected 2019 – does not include vaccines and diagnostic tests, as of September 2019
2. Evaluation using data from 2018 Altarum institute projection of non-retail drug expenditure for Medical Benefit Growth Rate; CMS, IQVIA and the 2019 Economic Report on US Pharmacies and PBMs, Drug Channels. Analysis assumes most medical drug spend is specialty.
3. Deloitte 2018 Study: The Convergence of Health Care Trends